Geron Appoints Vice President, Human Resources
June 20, 2019 16:27 ET
|
Geron Corporation
MENLO PARK, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the appointment of Shannon Odam as Vice President, Human Resources. Ms. Odam joins other...
Geron Reports Two Imetelstat Data Presentations at European Hematology Association Annual Congress
June 17, 2019 08:20 ET
|
Geron Corporation
Updated 8-week RBC-TI rate for the Phase 2 portion of IMerge increased to 42%, from 37% in December 2018Updated 24-week RBC-TI rate for the Phase 2 portion of IMerge increased to 29%, from 26% in...
Geron to Webcast KOL Event on June 25, 2019
June 10, 2019 16:45 ET
|
Geron Corporation
MENLO PARK, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that the Company will webcast an event on June 25, 2019, featuring key opinion leaders (KOLs)...
Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association
June 10, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 10, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics Announces Presentations at Three Upcoming Conferences
May 28, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 28, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Geron Announces Two Presentations on Imetelstat at Upcoming European Hematology Association Annual Congress
May 16, 2019 09:05 ET
|
Geron Corporation
MENLO PARK, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that two abstracts containing clinical data and analyses related to imetelstat, the Company’s...
Geron Continues to Build Senior Leadership of Its Development Team
May 16, 2019 06:00 ET
|
Geron Corporation
MENLO PARK, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it is continuing to build the senior leadership of its development team with the addition...
Onconova Therapeutics, Inc. Reports Business Highlights and First Quarter 2019 Financial Results
May 14, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...
Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater China
May 13, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
Onconova to Receive $4 Million Upfront, including $2 Million Fee and $2 Million for Onconova Shares Purchased at a Premium, Plus up to $45.5 Million in Regulatory and Sales Milestones for Rigosertib...
Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2019 Financial Results
May 07, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 07, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...